Shattuck Labs (STTK) Cash from Operations (2019 - 2026)
Shattuck Labs (STTK) reported Cash from Operations of 13424000.0 for Q1 2026, down 11.57% year-over-year from 15180222.56 in Q1 2025, and down 58.12% quarter-over-quarter from 8490000.0 in Q4 2025.
Shattuck Labs (STTK) Cash from Operations (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 8 years of Cash from Operations data on file, last reported at 13424000.0 in Q1 2026.
- Cash from Operations for Q1 2026 came in at 13424000.0, down 11.57% year-over-year; the trailing twelve-month figure through Mar 2026 was 41274000.0 (up 26.8% YoY), and the FY2025 annual result was 39882000.0, up 34.1% from the prior year.
- Cash from Operations eased to 13424000.0 in Q1 2026 per STTK's latest filing, from 8490000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 8490000.0 in Q4 2025 and troughed at 28064000.0 in Q3 2022.
- A 5-year average of 17032176.47 and a median of 16316000.0 in 2022 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2022 and 2025: Cash from Operations sank 137.41% in 2022, then jumped 51.12% in 2025.
- A 5-year view of Cash from Operations shows it stood at 23841000.0 in 2022, then climbed by 18.55% to 19419000.0 in 2023, then grew by 10.55% to 17370000.0 in 2024, then jumped by 51.12% to 8490000.0 in 2025, then sank by 58.12% to 13424000.0 in 2026.
- Business Quant data shows STTK's Cash from Operations at 13424000.0 in Q1 2026, 8490000.0 in Q4 2025, and 8929000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Shattuck Labs | 190.32 Mn | 190.32 Mn | - | -13.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.42 Mn |
| Mar 31, 2026 | -13.42 Mn |
| Dec 31, 2025 | -8.49 Mn |
| Dec 31, 2025 | -8.49 Mn |
| Sep 30, 2025 | -8.93 Mn |
| Sep 30, 2025 | -8.93 Mn |
| Jun 30, 2025 | -10.43 Mn |
| Jun 30, 2025 | -10.43 Mn |
| Mar 31, 2025 | -12.03 Mn |
| Mar 31, 2025 | -12.03 Mn |
| Dec 31, 2024 | -17.37 Mn |
| Dec 31, 2024 | -17.37 Mn |
| Sep 30, 2024 | -16.07 Mn |
| Sep 30, 2024 | -16.07 Mn |
| Jun 30, 2024 | -10.92 Mn |
| Jun 30, 2024 | -10.92 Mn |
| Mar 31, 2024 | -16.16 Mn |
| Mar 31, 2024 | -16.16 Mn |
| Dec 31, 2023 | -19.42 Mn |
| Dec 31, 2023 | -19.42 Mn |